资讯库
更紧凑的生命科学资讯库。
先搜索，再按来源或主题继续收窄。
葛兰素史克与阿纳普蒂生物就十年期Jemperli许可协议对簿公堂
GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014. On Thursday, GSK said T...
先搜索，再按来源或主题继续收窄。
GSK subsidiary Tesaro and AnaptysBio are at legal loggerheads over a licensing pact concerning the cancer drug Jemperli that dates back to 2014. On Thursday, GSK said T...